J
John C. Castle
Researcher at University of Mainz
Publications - 90
Citations - 16680
John C. Castle is an academic researcher from University of Mainz. The author has contributed to research in topics: Gene & Alternative splicing. The author has an hindex of 41, co-authored 80 publications receiving 15196 citations. Previous affiliations of John C. Castle include Merck & Co..
Papers
More filters
Journal ArticleDOI
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lee P. Lim,Nelson C. Lau,Philip W. Garrett-engele,Andrew Grimson,Janell M. Schelter,John C. Castle,David P. Bartel,Peter S. Linsley,Jason M. Johnson +8 more
TL;DR: These results suggest that metazoan miRNAs can reduce the levels of many of their target transcripts, not just the amount of protein deriving from these transcripts, and seem to downregulate a far greater number of targets than previously appreciated.
Journal ArticleDOI
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
Jason M. Johnson,John C. Castle,Philip W. Garrett-engele,Zhengyan Kan,Patrick M. Loerch,Christopher D. Armour,Ralph Santos,Eric E. Schadt,Roland Stoughton,Daniel D. Shoemaker +9 more
TL;DR: These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events and indicate that at least 74% of human multi-exon genes are alternatively spliced.
Journal ArticleDOI
An integrative genomics approach to infer causal associations between gene expression and disease
Eric E. Schadt,John Lamb,Xia Yang,Jun Zhu,Steve Edwards,Debraj GuhaThakurta,Solveig K. Sieberts,Stephanie A. Monks,Marc L. Reitman,Chunsheng Zhang,Pek Yee Lum,Amy Leonardson,Rolf Thieringer,Joseph M. Metzger,Liming Yang,John C. Castle,Haoyuan Zhu,Shera F Kash,Thomas A. Drake,Alan B. Sachs,Aldons J. Lusis +20 more
TL;DR: It is shown that this approach can predict transcriptional responses to single gene–perturbation experiments using gene-expression data in the context of a segregating mouse population and the utility of this approach is demonstrated by identifying and experimentally validating the involvement of three new genes in susceptibility to obesity.
Journal ArticleDOI
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter,Mathias Vormehr,Niels van de Roemer,Mustafa Diken,Martin Löwer,Jan Diekmann,Sebastian Boegel,Barbara Schrörs,Fulvia Vascotto,John C. Castle,Arbel D. Tadmor,Stephen P. Schoenberger,Christoph Huber,Özlem Türeci,Ugur Sahin +14 more
TL;DR: The tailored immunotherapy approach introduced here may be regarded as a universally applicable blueprint for comprehensive exploitation of the substantial neo-epitope target repertoire of cancers, enabling the effective targeting of every patient’s tumour with vaccines produced ‘just in time’.
Journal ArticleDOI
Genome-Scale RNAi Screen for Host Factors Required for HIV Replication
Honglin Zhou,Min Xu,Qian Huang,Adam Gates,Xiaohua Douglas Zhang,John C. Castle,Erica Stec,Marc Ferrer,Berta Strulovici,Daria J. Hazuda,Amy S. Espeseth +10 more
TL;DR: In this article, the authors conducted a genome-scale siRNA screen, revealing more than 311 host factors, including 267 that were not previously linked to HIV, and found that there was little overlap between these genes and the HIV dependency factors described recently.